Citius Oncology, Inc. (CTOR) Debt Components
- 2026-06-30: Long-term Debt, GrossUSD $10.00M; Debt Instrument, Face AmountUSD (m); Notes Payable, CurrentUSD (m).
- 2024-09-30: Long-term Debt, GrossUSD (m); Debt Instrument, Face AmountUSD $3.80M; Notes Payable, CurrentUSD (m).
- 2024-08-16: Long-term Debt, GrossUSD (m); Debt Instrument, Face AmountUSD $3.80M; Notes Payable, CurrentUSD (m).
- 2024-06-30: Long-term Debt, GrossUSD (m); Debt Instrument, Face AmountUSD (m); Notes Payable, CurrentUSD $1.72M.
Citius Oncology, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Notes Payable, Current USD |
|---|---|---|---|
| 2026-06-30 | $10.00M | (m) | (m) |
| 2024-09-30 | (m) | $3.80M | (m) |
| 2024-08-16 | (m) | $3.80M | (m) |
| 2024-06-30 | (m) | (m) | $1.72M |
| 2024-03-31 | (m) | (m) | $1.52M |
| 2023-12-31 | (m) | (m) | $1.32M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |